Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | CTNNB1 | P35222 | 5/20 | 0.44 |
| ▸ | WNT3A | P56704 | 4/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.38 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | METAP1 | P53582 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8081581 | 1.00 | KMT2A (0.53) | KMT2ACTNNB1WNT3ATLR7ALDH1A1 | |
| Bromide SCHEMBL8081586 | 0.99 | KMT2A (0.54) | KMT2ACTNNB1WNT3ATLR7ALDH1A1 | |
| Bromide SCHEMBL3843812 | 0.99 | KMT2A (0.54) | KMT2ACTNNB1WNT3ATLR7ALDH1A1 | |
| SCHEMBL5071271 | 0.97 | KMT2A (0.52) | KMT2ACTNNB1WNT3ATLR7ALDH1A1 | |
| Bromide SCHEMBL5015757 | 0.87 | KMT2A (0.44) | KMT2ACTNNB1WNT3ATLR7ALDH1A1 | |
| Bromide SCHEMBL5978880 | 0.79 | ALDH1A1 (0.38) | KMT2AALDH1A1LMNANPC1RAB9A | |
| Alagebrium SCHEMBL1648822 | 0.77 | KMT2A (0.74) | KMT2AALDH1A1LMNAL3MBTL1OPRM1 | |
| Alagebrium SCHEMBL1820212 | 0.76 | KMT2A (0.71) | KMT2AALDH1A1LMNANPC1RAB9A | |
| Bromide SCHEMBL3894863 | 0.75 | KMT2A (0.53) | KMT2ACTNNB1WNT3ATLR7ALDH1A1 | |
| Bromide SCHEMBL3845240 | 0.75 | CTNNB1 (0.45) | KMT2ACTNNB1WNT3ATLR7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6121300-A | IN A TOPICAL COSMETIC AS SKIN ELASTICITY IMPROVER OR WRINKLE REDUCER; COMPOUNDS SUCH AS 3-(2-(3-PHENYL-5-ISOXAZOLYL)-2-OXOETHYL)-THIAZOLIUM; ADMINSISTERING TO TREAT CATARACTS, PROTEIN AGING AND DIABETES | SYNVISTA THERAPEUTICS, INC. | 2000-09-19 | — | — | US | disclosed |